diabetic macular edema


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

diabetic macular edema

Swelling of the retina resulting from leakage of fluids from damaged blood vessels in the eye. It is a major cause of visual loss in diabetics, and is related to poor control of blood glucose.
See also: edema
References in periodicals archive ?
Diabetic Macular Edema - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Alimera's sustained release intravitreal implant for the treatment of diabetic macular edema.
Data from a Phase 1b/2a study to explore the safety and efficacy of AKB-9778 in patients with diabetic macular edema is expected in 2013.
The trial is studying the use of Medidur(TM) FA for the treatment of diabetic macular edema (DME) being conducted by our licensing partner, Alimera Sciences.
These data suggest that ruboxistaurin may have the potential to decrease the progression of diabetic macular edema to involve the center of the macula.
For the first time, Americans with diabetic macular edema will have access to an FDA-approved medicine shown to help many patients rapidly regain substantial amounts of lost vision," said Hal Barron, M.
About Diabetic Macular Edema (DME) Diabetic macular edema (DME) or "swelling of the macula" is a common complication in the eyes of patients with diabetes.
The proceeds will support ongoing development of Aerpio s pipeline, including AKB-9778, which is entering Phase 1b/2a for the treatment of diabetic macular edema (DME).
3 mg dose of Lucentis([R])(ranibizumab injection) for treatment of diabetic macular edema (DME).
Food and Drug Administration (FDA) approval and advantages of ILUVIEN for the long-term treatment of diabetic macular edema (DME) during the Device, Delivery and Diagnostic Company Showcase on Thursday, October 16, 2014.
This experience, combined with her expertise in clinical trial design, will prove valuable to Aerpio as we recently completed a Phase 1 trial of AKB-9778 for the treatment of diabetic macular edema and expect to initiate a Phase 1b/2a study in this indication this quarter.
25, 2014 /PRNewswire/ -- EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023 Summary Macular edema (ME) occurs due to the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision.